315 related articles for article (PubMed ID: 22098435)
1. Urinary 8-hydroxy-2'-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease.
Zengi O; Karakas A; Ergun U; Senes M; Inan L; Yucel D
Clin Chem Lab Med; 2011 Nov; 50(3):529-34. PubMed ID: 22098435
[TBL] [Abstract][Full Text] [Related]
2. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G
J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407
[TBL] [Abstract][Full Text] [Related]
3. LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease.
Cagnin A; Leon A; Vianello D; Colavito D; Favaretto S; Zarantonello G; Stecca A; Ermani M; Zambon A
J Alzheimers Dis; 2013; 34(2):377-85. PubMed ID: 23207490
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.
Mecocci P; Polidori MC; Cherubini A; Ingegni T; Mattioli P; Catani M; Rinaldi P; Cecchetti R; Stahl W; Senin U; Beal MF
Arch Neurol; 2002 May; 59(5):794-8. PubMed ID: 12020262
[TBL] [Abstract][Full Text] [Related]
5. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
6. Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.
Lőrincz H; Harangi M; Oláh AV; Szabó GP; Fülöp P; Somodi S; Paragh G; Seres I
Pediatr Res; 2015 May; 77(5):703-9. PubMed ID: 25668223
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
[TBL] [Abstract][Full Text] [Related]
9. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice.
Zhang C; Rissman RA
PLoS One; 2017; 12(7):e0181367. PubMed ID: 28750017
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
[TBL] [Abstract][Full Text] [Related]
13. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Viktorinova A; Svitekova K; Stecova A; Krizko M
Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
15. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
[TBL] [Abstract][Full Text] [Related]
16. 8-Hydroxydeoxyguanosine levels in human leukocyte and urine according to exposure to organophosphorus pesticides and paraoxonase 1 genotype.
Lee CH; Kamijima M; Kim H; Shibata E; Ueyama J; Suzuki T; Takagi K; Saito I; Gotoh M; Hibi H; Naito H; Nakajima T
Int Arch Occup Environ Health; 2007 Jan; 80(3):217-27. PubMed ID: 16915393
[TBL] [Abstract][Full Text] [Related]
17. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Damage of DNA as Early Marker of Alzheimer's Disease.
Peña-Bautista C; Tirle T; López-Nogueroles M; Vento M; Baquero M; Cháfer-Pericás C
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817451
[TBL] [Abstract][Full Text] [Related]
19. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.
Mehdi MM; Rizvi SI
Arch Med Res; 2012 Aug; 43(6):438-43. PubMed ID: 22959975
[TBL] [Abstract][Full Text] [Related]
20. Serum HDL Associated Antioxidant Activity in Alzheimer's Disease: Paraoxonase1 and Dysfunctional HDL.
Varlibas F; Akhan O; Can M; Yuksel G; Gul ZB
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
